Insider · CIK 0001380710
George Eric Davis
Files at BMRN (BIOMARIN PHARMACEUTICAL INC). First filing Feb 26, 2026, latest Sep 3, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BMRN: BIOMARIN PHARMACEUTICAL INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | BMRNsell BIOMARIN PHARMACEUTICAL INC | $1.2M 17,557 shares | -22% | - | |
| 65Notable | BIOMARIN PHARMACEUTICAL INC | $1.6M 26,061 shares | -26% | +19% from low-16% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | SOpen-market sale Common Stock | -17,557 | $66.28 | $1.2M | 61,003 | 39 d ago |
| Mar 18, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock | -1,273 | $56.05 | $71k | 78,560 | Mar 19, 2026 |
| Mar 16, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock | -7,177 | $58.51 | $420k | 65,263 | Mar 17, 2026 |
| Mar 16, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +14,570 | $0.00 | $0 | 79,833 | Mar 17, 2026 |
| Mar 16, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Stock Option (Right to Buy Common Stock)derivative | +34,690 | $0.00 | $0 | 34,690 | Mar 17, 2026 |
| Feb 25, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +6,177 | $0.00 | $0 | 89,467 | Feb 26, 2026 |
| Feb 25, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +6,675 | $0.00 | $0 | 96,142 | Feb 26, 2026 |
| Feb 25, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +2,372 | $0.00 | $0 | 98,514 | Feb 26, 2026 |
| Feb 26, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | SOpen-market sale Common Stock | -26,061 | $61.36 | $1.6M | 72,453 | Feb 26, 2026 |
| Mar 14, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock | -16,249 | $69.44 | $1.1M | 69,975 | Mar 18, 2025 |
| Mar 17, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +12,940 | $0.00 | $0 | 82,915 | Mar 18, 2025 |
| Mar 17, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Stock Option (Right to Buy Common Stock)derivative | +30,020 | $0.00 | $0 | 30,020 | Mar 18, 2025 |
| Feb 25, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +11,040 | $0.00 | $0 | 67,197 | Feb 27, 2025 |
| Feb 25, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +9,660 | $0.00 | $0 | 76,857 | Feb 27, 2025 |
| Feb 25, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +9,367 | $0.00 | $0 | 86,224 | Feb 27, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.